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cytokines. Cytokines are a diverse group of signaling proteins that
are transiently produced in response to an immune challenge [7].
Their biological effects include activating and recruiting immune
cells causing inflammation. Physiologically, interleukin(IL)-1β
and tumor necrosis factor (TNF)-α play a role in causing uterine
contractions and cervical ripening by producing prostaglandins
and recruiting leukocytes. Further, IL-6, IL-8, TNF-α, and macrophage inflammatory protein (MIP)-1α have been implicated in
the pathogenesis of the fetal inflammatory response syndrome
(FIRS) and play a predominant role in term and preterm delivery,
independent of the presence of infection [8,9].
It has been observed that a greater inflammatory response in
males could lead to early preterm labour [10,11], which may avoid
the opportunity for other infection-related pregnancy complications. While the female fetus would display signs of infection
of placenta and membranes, the male fetus would, through an
increased cytokine response, initiate labour before signs of infection become apparent. This has led us to postulate that genderspecific differences exist in fetal plasma, in the adaptive immune
response of proinflammatory cytokines to bacterial challenge.
The objectives of this study were to establish these differences in
immune response, providing further insight into gender-specific
immunological responses in adverse pregnancy outcomes.

Introduction

Materials and methods

Gender differences have been associated with differences in
mortality and morbidity of the fetus with the male fetus experiencing worse outcome following complications such as preterm
delivery and infection [1]. Women carrying male fetuses have
a higher incidence of pregnancy complications such as spontaneous abortions, preterm birth and preterm premature rupture
of membranes (PPROM) [1–3]. These differences in outcomes
have also been observed in adults following trauma or major
surgery [4]. Several studies have demonstrated a higher incidence
of sepsis or multiple organ failure in males and noted that male
gender was an independent risk factor for major infection [4,5].
These differences have been attributed to increased cytokine
response in males [6].
The maternal–fetal–placental unit is able to combat an infection
through an adaptive immune response via several inflammatory

The study was approved by The University of Western Ontario
Research Ethics Board for the review of Health Sciences Research
involving Human Subjects (HSREB). The study comprised of 45
pregnant women and their single neonate attending St Joseph’s
Health Care London (SJHC), London, Ontario, Canada. All
pregnant women had scheduled (unlaboured) elective caesarean
sections, following uncomplicated pregnancies. Inclusion criteria
were growth appropriate for gestational age, Apgar scores of >7
at 1 and 5 min and a normal placenta in appearance and weight.
After informed consent was obtained, 5 mL of maternal venous
blood was collected from the antecubital fossa into sterile tubes,
approximately 2 h prior to caesarean section. Immediately after
birth 5 mL of fetal venous blood was drawn into sterile tubes from
the umbilical cord. Blood samples were either centrifuged for
15 min at 500×g after sampling and plasma frozen at −80°C for later

Objectives: To establish gender-specific differences in maternal
and fetal immune response in healthy human fetuses at term.
Methods: Forty-five women with elective caesarean sections for
uncomplicated singleton pregnancies were recruited for two
studies. Using a multiplex biomarker immunoassay system,
unstimulated maternal and fetal plasma concentrations of
interleukin (IL)-1β, IL-1ra, IL-6, IL-8, macrophage inflammatory protein (MIP)-1α, and tumor necrosis factor (TNF)-α were
measured from one study population. Lipopolysaccharide (LPS)stimulated cytokine response was measured in a second study.
Results: There were no significant gender differences in either
maternal or fetal unstimulated plasma cytokine concentrations,
but concentrations of the proinflammatory cytokines IL-1β
and IL-6 were significantly greater in male fetal LPS-stimulated
samples than in female fetal samples. Conclusions: Blood of
male fetuses mounts a larger pro-inflammatory response to
lipopolysaccharide (LPS). This heightened response could be a
critical pathway in promoting premature rupture of membranes
(PPROM) and may be associated with life long differential
gender response to infection.
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assay as unstimulated samples or processed prior to centrifugation
as below for lipopolysaccharide (LPS)-stimulated studies.
Determination of basal maternal and fetal cytokine
concentrations
Cytokine levels in the supernatants of unstimulated collections
(n = 8 female, n = 11 male) were measured using a Multiplex
Immunoassay (Lincoplex, Millipore Corp, MA, USA), with a
Bio-Plex™ 200 Readout System (Bio-Rad Laboratories, Hercules,
CA, USA), which utilizes Luminex® xMAP™ fluorescent beadbased technology (Luminex Corp., Austin, TX, USA). Cytokine
levels were automatically calculated from standard curves using
Bio-Plex Manager software (v.4.1.1, Bio-Rad Laboratories,
Hercules, CA, USA).
Lipopolysaccharide-stimulated cytokine response of maternal
and fetal blood
Immediately following blood collection (n = 9 female fetuses,
n = 15 male fetuses), maternal and fetal blood samples were
diluted 1:10 with RPMI-1640 medium, enriched with 2 mM
l-glutamine. Diluted blood was then placed into wells (1 mL)
and Escherichiae coli K12–LCD25 lipopolysaccharide (LPS)
was added to the treatment group at a dose of 100 ng/mL
[12]. After 4 h of incubation at 37°C/21% O2, well contents
were collected and centrifuged at 3600 rpm for 10 min and
the supernatant then collected and stored at −80°C until assay.
The 4-h incubation was used based on previous fetal cytokine
response studies [13] and our observation of attainment of
differential cytokine (IL-6) responses at this time point in a
limited number of samples (data not shown).The cytokines,
IL- 1β, IL-1ra, IL-6, IL-8, MIP-1α and TNF-α were measured
in unstimulated and LPS-stimulated supernatant after 4 h
of incubation using the Multiplex Biomarker Immunoassay
system as described above.
Statistical analysis
Unstimulated maternal and fetal samples gender comparisons
were analyzed separately by Mann–Whitney test and are presented
as mean ± SEM. LPS-stimulated data displayed unequal variance
and were transformed and Kruskal–Wallis with Dunns post test
ANOVA applied and are presented as mean ± SEM. A p value
<0.05 was considered statistically significant.

Results
Patient population
There were no significant differences in base demographics of the
study population of patients undergoing elective caesarean section
giving birth to males or females in either the unstimulated or the
LPS-stimulated study. Likewise, there were no significant differences between genders in the demographics of the neonatal population (Table I).
Determination of basal maternal and fetal cytokine
concentrations
Basal levels of IL-1ra, IL-6, IL-8, MIP-1α, and TNF-α, but not IL-1β
were detected in fetal and maternal plasma collected from elective
caesarean section. There were no significant differences in either
maternal or fetal plasma concentrations of the various cytokines
between pregnancies bearing male and female fetuses (Table II).

© 2012 Informa UK, Ltd.

Table I. Demographic data of participating mothers and neonates.
Female fetus
Male fetus
Unstimulated baseline cytokine study
Maternal age (years)
35.3 ± 1.7
31.6 ± 1.5
Gestational age (weeks)
38.7 ±.03
39.1 ± 0.1
Placental weight (g)
636.0 ± 58.1
690.2 ± 48.3
Birth weight (g)
3219.5 ± 191.6
3629.6 ± 135.6
8.4 ± 0.5
9.6 ± 0.6
Predelivery maternal leukocyte
count(×109 units/L)
Unstimulated and LPS-stimulated study
Maternal age (yrs)
28.7 ± 4.3
31.8 ± 3.2
Gestational age (wks)
37.9 ±.0.9
38.1 ± 0.8
Placental weight (g)
906.0 ± 188.9
767.5 ± 156.4
Birth weight (g)
3651.0 ± 526.8
3545.7 ± 525.1
10.4 ± 2.8
10.2 ± 1.7
Predelivery maternal leukocyte
count (×109 units/L)
Data are mean ± SEM
Unstimulated baseline cytokine study (female = 8, male = 11).
Unstimulated and LPS-stimulated study (female = 9, male = 15).

Table II. Unstimulated maternal cytokine concentrations (pg/mL) for
pregnancies carrying female or male fetuses.
Maternal cytokine concentrations Fetal cytokine concentrations
Female fetus
Male fetus
Female fetus
Male fetus
IL-1ra
397.48 ± 185.04 230.478 ± 122.28 102.14 ± 33.89 72.98 ± 12.11
IL-6
53.88 ± 22.59
58.06 ± 24.61
10.19 ± 3.78 26.73 ± 14.50
IL-8
21.92 ± 7.07
25.00 ± 7.72
9.33 ± 1.56 11.48 ± 2.91
TNF-α
15.75 ± 5.66
10.79 ± 1.66
20.59 ± 2.65 19.46 ± 2.13
MIP-1α 35.01 ± 12.15
28.37 ± 7.35
7.46 ± 1.47 9.33 ± 2.65
Mean ± SEM (female = 8, male = 11).
IL, interleukin; MIP, macrophage inflammatory protein; TNF, tumor necrosis factor.

Lipopolysaccharide-stimulated cytokine response of maternal
and fetal blood
Following a 4 h LPS exposure, there was a significant increase in all
cytokine levels in both maternal and fetal samples from baseline,
however there were no significant gender differences in maternal
cytokine levels (Table III). Cytokine levels in fetal blood + LPS
samples compared with the control unstimulated states were
also significantly increased (Table IV). There were no significant
gender differences in LPS-stimulated cytokine levels for IL-1ra,
IL-8, MIP-1α, and TNF-α levels (Table IV). However, levels of
the proinflammatory cytokines IL-1β and IL-6 were significantly
greater in male fetal LPS-stimulated samples than in female fetal
samples (Figures 1 and 2).

Discussion
By examining healthy, non-laboured fetuses at term, we were able
to establish the gender-specific baseline levels of several inflammatory cytokines, which are known to contribute to the adaptive
fetal immune response, and observed the effect of stimulation
with lipopolysaccharide (LPS). We established that all cytokines
analyzed show an increase in response to a LPS challenge. We
did not observe a gender-specific difference in maternal or fetal
plasma cytokines at baseline, however, we did find a genderspecific difference in cytokine response in fetal plasma, but not
in maternal plasma, after LPS exposure. Specifically, there was a
significantly greater response in IL-1β and IL-6 in male compared
to female fetal blood.
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Table III. Cytokine concentrations (pg/mL) following a 4 h incubation
of maternal (female and male pregnancies) blood with 100 ng/mL LPS
(stimulated).
Female fetus +LPS
Male fetus +LPS
IL-1β
39.62 ± 49.93
94.87 ± 76.70
IL-1ra
374.79 ± 273.58
299.11 ± 65.53
IL-6
804.00 ± 505.58
1335.28 ± 904.00
IL-8
208.38 ± 192.73
158.63 ± 116.87
TNF-α
267.32 ± 179.02
232.16 ± 139.16
MIP-1α
1741.22 ± 2136.92
1509.32 ± 2579.93
Mean ± SEM. Female (n = 9) + LPS and male (n = 15) + LPS.
LPS, lipopolysaccharide; IL, interleukin; MIP, macrophage inflammatory protein; TNF,
tumor necrosis factor.

Table IV. Cytokine concentrations (pg/mL) following a 4 h incubation of
fetal (female and male pregnancies) blood without (unstimulated) or with
100 ng/mL LPS (stimulated).
Female
Male
unstimulated Female + LPS unstimulated
Male + LPS
IL-1β
0.24 ± 0.02
33.60 12.05
0.93 ± 0.40
136.09 ± 26.96#
IL-1ra
8.25 ± 2.49 420.32 ± 112.31 10.80 ± 4.29
470.26 ± 134.62
IL-6
1.12 ± 0.46 927.33 ± 126.90
2.43 ± 0.70 2229.25 ± 378.93*
IL-8
1.76 ± 0.48 489.63 ± 126.52
9.86 ± 7.26
628.12 ± 105.73
MIP-1α 6.76 ± 2.79 1318.18 ± 226.30
8.80 ± 1.72 2231.33 ± 520.61
TNF-α
1.06 ± 0.32 246.86 ± 49.59
3.83 ± 2.76
245.95 ± 36.39
Mean ± SEM. Significant differences between female (n = 9) + LPS and male (n = 15) +
LPS are noted.
LPS, lipopolysaccharide; IL, interleukin; MIP, macrophage inflammatory protein; TNF,
tumor necrosis factor.
#p < 0.01 and *p < 0.01.

Figure 1. Media interleukin (IL)-1β concentration following a 4 h incubation
of fetal female and male blood without (unstimulated) and with 100 ng/
mL lipopolysaccharide (LPS). Unstimulated female and male samples were
combined. Data were analyzed with Kruskal–Wallis ANOVA with Dunns post
test. Female + LPS and male + LPS were significantly elevated (**p < 0.01 and
***p < 0.001, respectively) compared with pooled unstimulated samples. Male
+ LPS concentrations were significantly elevated compared to female + LPS
(#p < 0.01).

During pregnancy, the maternal and fetal immune systems
are intricately linked through the placenta, and proper functioning of both systems is necessary for a healthy, successful
pregnancy. The onset of term or preterm labour is associated
with a cytokine-activated immune response [14] and progesterone withdrawal removes constraints on the immune system
and permits inflammation and labour [15]. IL-6, TNF-α, and

Figure 2. Media interleukin (IL)-6 concentration following a 4 h incubation
of fetal female and male blood without (unstimulated) and with 100 ng/
mL lipopolysaccharide (LPS). Unstimulated female and male samples were
combined. Data were analyzed with Kruskal–Wallis ANOVA with Dunns post
test. Female + LPS and male + LPS were significantly elevated (**p < 0.01 and
***p < 0.001, respectively) compared with pooled unstimulated samples. Male
+ LPS concentrations were significantly elevated compared to female +LPS
(#p < 0.01).

MIP-1α have been implicated in the pathogenesis of FIRS, which
is considered the fetal counterpart of the systemic inflammatory
response syndrome observed in adults. FIRS has been described
in association with intra-amniotic infection in fetuses, regardless
of membrane rupture, and it is an independent risk factor for
impending preterm labor and delivery, perinatal morbidity and/
or mortality [9].
Bacterial infections, leading to a premature inflammation, pose
a significant threat to pregnancy and the proper development
of the fetus. Inflammatory changes have been associated with
PPROM, chorioamnionitis, and funisitis [11]. Likewise, infections have been reported as responsible for up to 40% of preterm
labour, and 80% of preterm deliveries show signs of infection.
Proinflammatory cytokines such as IL-1β, IL-6, IL-8, TNF-α, and
MIP-1α have all been increased in neonatal cord blood following
pregnancies involving these inflammatory complications [16].
Given the critical role cytokines play in the induction of partition, increases in the cytokines such as IL-1β and IL-6 would
be associated with a predisposition to preterm labour and the
sequelae of prematurity in neonates. Indeed, concentrations of
the proinflammatory cytokine IL-6 are increased in amniotic fluid
of pregnancies affected by PPROM compared to amniotic fluid
obtained from pregnancies with intact membranes [17]. These
changes are found in concert with high concentrations of IL-1ra
in amniotic fluid and umbilical venous blood suggesting that the
presence of this anti-inflammatory cytokine serves to prevent the
development of overt inflammation [17]. Our results concur with
the findings of increased IL-6 expression in the setting of an infection, through ex-vivo stimulation with LPS. The gender-specific
difference in IL-6 in fetal plasma observed in our study provides
a possible explanation for the increased incidence of PPROM and
preterm labour occurring in male fetuses compared to female
fetuses.
Systemic administration of IL-1 induces preterm labor and
delivery in mice [18], highlighting IL-1 as an important contributor in modulation of inflammation related to chorioamnionitis
and preterm labour in the fetoplacental compartment. In our
study, incubation of fetal male blood with LPS induced a greater
response of IL-1β, a response similar to the previously described
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increased levels of IL-1β in adult males after significant trauma
or infection [19]. The actions of IL-1 are modulated by the antiinflammatory cytokine, Interleukin-1 receptor antagonist (IL-1ra),
commonly present in amniotic fluid. IL-1ra inhibits the effects
of IL-1 and can prevent preterm delivery induced by IL-1 [20].
Although our current study found no gender associated differences
in the levels of IL-1ra, the concentration of IL-1ra in amniotic fluid
has been reportedly significantly higher in female fetuses than male
fetuses both at preterm and term gestation [11]. While the presence
of gender differences in IL-1ra could explain improved outcomes
in pregnancies bearing female fetuses in complications of preterm
labour or chorioamnionitis, we did not observe this role for IL-1ra,
either in the basal or LPS-stimulated situation.
The expression of the cytokines, MIP-α and IL-8 is increased
in term placental syncytiotrophoblast cells when stimulated by
bacterial LPS [21], which ultimately increases the response of the
immune system [22]. Specifically, MIP-1α recruits leukocytes to
the site of infection, resulting in a local inflammatory response and
IL-8 recruits neutrophils to phagocytose an infectious agent. The
immune response of fetal blood in our study appears to follow the
same activation pattern as observed in term placental syncytrophoblast studies [21], and both genders mount a similar significant
response. While the current study is adequately powered to detect
gender differences after stimulation in fetal IL-1β (power 0.96) and
IL-6 (0.98), the study is limited in power to detect possible smaller
gender differences in some of the other cytokines, such as MIP-α
(sample size 49, for α = 0.05 and power = 0.80) and IL-8 (sample
size 123). The interactions between the different cytokines are
therefore likely more complex than demonstrated.
Overall, our data provides support for the important concept
that gender difference in immune response is established in utero
and remain constant throughout one’s lifetime. In adulthood, it
has been shown that males and females respond differently to a
bacterial infection in both total immune response and steepness
of the response curve [23]. Specifically, adult females have been
found to have a 30% lower immune response compared to males
[24] and it is suggested that following an infectious challenge,
elevated plasma cytokine levels are inversely correlated to positive
outcome [23]. Our results provide support for a parallel between
the fetal and adult immune response [23], with a significantly
greater release of proinflammatory cytokines following bacterial
stimulation in male fetal plasma. One potential explanation for
this gender difference is the sexual dimorphism in hormones
influencing the LPS-stimulated signaling pathway [24]. Studies
have also shown that testosterone, which is predominant in males,
contributes to a weaker immune response, whereas estrogen
seems to be protective [24]. Preterm females have significantly
higher catecholamine levels than males, which may explain the
better outcome in females after a hypoxic event [1].
This study provides an important insight into gender associated cytokine response to a bacterial challenge in cord blood and
forms the basis for ongoing studies into the relation between
fetal gender and pregnancy outcome. We report that IL-1β and
IL-6, important inflammatory cytokines in the labour pathway,
display differential inflammatory responses to LPS, based on
gender. This heightened response in male fetuses could be a
critical pathway in promoting PPROM or preterm labour and
may be associated with lifelong differential gender response to
infection. Clinically, this study demonstrates that gender differences in immune response exist as early as in fetal life, are likely
to affect pregnancy outcome and should be taken into account
in all investigations regarding cytokine response in pregnancy.

© 2012 Informa UK, Ltd.
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